UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 866

Sortiert nach

Teaching computing and experiencing grief in the year 1 AC (after ChatGPT)

Frontiers in education (Lausanne), 2024-03, Vol.9

James Geller

2024

Link zum Volltext

Verfügbarkeit prüfen

Health Information Science: 5th International Conference, HIS 2016, Shanghai, China, November 5-7, 2016, Proceedings

1st Edition 2016, 2016

Link zum Volltext

Verfügbarkeit prüfen

Treatment of advanced pediatric renal cell carcinoma

Pediatric blood & cancer, 2019-08, Vol.66 (8), p.e27766-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration

Journal of clinical oncology, 2015-09, Vol.33 (27), p.2999-3007

2015

Link zum Volltext

Verfügbarkeit prüfen

Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1558-1568

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients

Molecular therapy, 2015-03, Vol.23 (3), p.602-608

2015

Link zum Volltext

Verfügbarkeit prüfen

Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532

Journal of clinical oncology, 2018-01, Vol.36 (3), p.254-261

2018

Link zum Volltext

Verfügbarkeit prüfen

Current standards of care and future directions for “high-risk” pediatric renal tumors: Anaplastic Wilms tumor and Rhabdoid tumor

Urologic oncology, 2016, Vol.34 (1), p.50-56

Geller, James I., M.D

2016

Link zum Volltext

Verfügbarkeit prüfen

Pancreatic Masses in Children and Young Adults: Multimodality Review with Pathologic Correlation

Radiographics, 2021-10, Vol.41 (6), p.1766-1784

2021

Link zum Volltext

Verfügbarkeit prüfen

A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot consortium trial (ADVL1315)

Cancer, 2018-12, Vol.124 (23), p.4548-4555

2018

Link zum Volltext

Verfügbarkeit prüfen

The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing

Cancer, 2018-08, Vol.124 (16), p.3381-3389

2018

Link zum Volltext

Verfügbarkeit prüfen

Children's Oncology Group's 2013 blueprint for research: Renal tumors

Pediatric blood & cancer, 2013-06, Vol.60 (6), p.994-1000

2013

Link zum Volltext

Verfügbarkeit prüfen

Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group

Annals of surgery, 2017-09, Vol.266 (3), p.470-478

2017

Link zum Volltext

Verfügbarkeit prüfen

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group

Journal of clinical oncology, 2016-09, Vol.34 (26), p.3189-3194

2016

Link zum Volltext

Verfügbarkeit prüfen

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report

Journal of clinical oncology, 2019-10, Vol.37 (30), p.2769-2777

2019

Link zum Volltext

Verfügbarkeit prüfen

ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma—A Children's Oncology Group study

Cancer, 2020-12, Vol.126 (24), p.5303-5310

2020

Link zum Volltext

Verfügbarkeit prüfen

Review of phase I and II trials for Wilms' tumour – Can we optimise the search for novel agents?

European journal of cancer (1990), 2017-07, Vol.79, p.205-213

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study

Journal of clinical oncology, 2018-06, Vol.36 (16), p.1564-1570

2018

Link zum Volltext

Verfügbarkeit prüfen

Outcome analysis of stage I epithelial‐predominant favorable‐histology Wilms tumors: A report from Children's Oncology Group study AREN03B2

Cancer, 2020-06, Vol.126 (12), p.2866-2871

2020

Link zum Volltext

Verfügbarkeit prüfen

Skeletal muscle mass as a marker to predict outcomes in children and young adults with cancer

Abdominal radiology (New York), 2022, Vol.47 (1), p.452-459

2022

Link zum Volltext

Verfügbarkeit prüfen

Children's Oncology Group's 2023 blueprint for research: Renal tumors

Pediatric blood & cancer, 2023-09, Vol.70 (S6), p.e30586-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma

Modern pathology, 2014-09, Vol.27 (9), p.1267-1280

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature

Cancers, 2021-06, Vol.13 (13), p.3142

2021

Link zum Volltext

Verfügbarkeit prüfen

Germline APC mutations in hepatoblastoma

Pediatric blood & cancer, 2018-04, Vol.65 (4), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors

Clinical cancer research, 2017-05, Vol.23 (10), p.2433-2441

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 866

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(730)
Mit Volltextzugriff
(760)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(549)
Life Sciences & Biomedicine
(458)
Humans
(373)
Female
(214)
Male
(180)
Oncology
(119)
Child
(112)
Technology
(112)
Computer Science
(109)
Adult
(101)
Pediatrics
(98)
Biological And Medical Sciences
(94)
Middle Aged
(93)
Medical Sciences
(86)
Adolescent
(84)
Aged
(77)
Treatment Outcome
(69)
Surgery
(63)
Computer Science, Information Systems
(56)
Child, Preschool
(55)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Teaching computing and experiencing grief in the year 1 AC (after ChatGPT)

Health Information Science: 5th International Conference, HIS 2016, Shanghai, China, November 5-7, 2016, Proceedings

Treatment of advanced pediatric renal cell carcinoma

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration

Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study

Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients

Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532

Current standards of care and future directions for “high-risk” pediatric renal tumors: Anaplastic Wilms tumor and Rhabdoid tumor

Pancreatic Masses in Children and Young Adults: Multimodality Review with Pathologic Correlation

A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot consortium trial (ADVL1315)

The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing

Children's Oncology Group's 2013 blueprint for research: Renal tumors

Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report

ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma—A Children's Oncology Group study

Review of phase I and II trials for Wilms' tumour – Can we optimise the search for novel agents?

Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study

Outcome analysis of stage I epithelial‐predominant favorable‐histology Wilms tumors: A report from Children's Oncology Group study AREN03B2

Skeletal muscle mass as a marker to predict outcomes in children and young adults with cancer

Children's Oncology Group's 2023 blueprint for research: Renal tumors

DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma

Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature

Germline APC mutations in hepatoblastoma

A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors

Suchergebnisse filtern